Today’s top gainers include the company AbbVie Inc. (NYSE:ABBV) which is in the industry Drug Manufacturers – Major, gaining -1.78% today. In the last week its performance is 1.18%, and 8.26% for the past quarter. Currently, AbbVie Inc., ABBV has a target price of 70, so today’s gain of -1.78% is a significant step towards its target price. The GAP today is therefore -1.65%.
AbbVie Inc. (NYSE:ABBV), has a market cap of 101725.83, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 71.00%.
At the current price of 63.62, it has a dividend yield of 3.58%, and its target price is 70. This is with a profit margin of 23.00%, and total debt/equity of 6.87. AbbVie Inc. (NYSE:ABBV) has a P/E of 19.06, as well as a forward P/E of 11.33.
With a current EPS of 3.34, and a forecasted EPS growth for next year at 17.87%,AbbVie Inc. (NYSE:ABBV) has had a EPS growth for the past five years at 3.50%. For the next five years EPS growth is projected to be 16.39%.
Performance for the year is -5.26%. Since its IPO date on 1/2/2013, the total performance to date is 10.53%.
Volume today for AbbVie Inc. (NYSE:ABBV), is 12083386, while its average volume is 9075.11. Whilst the total gain today was -1.78%, it did have a day high of -2.48%.
Volatility for this week has been at 1.93%, and 1.94% for the month. The 52-week low for AbbVie Inc., ABBV has been 44.06%, while the 52-week-high has reached -7.71%.
Looking at its return of investments, which is 16.90%, and its return on assets is 10.20%. AbbVie Inc. (NYSE:ABBV) has an operating margin of 34.20%. With a sales growth of 18.20% quarter over quarter. Bearing in mind that AbbVie Inc., ABBV is in the sector Healthcare, its long-term debt/equity is 6.35, and has a current ratio of 1.6 and 1.4 for quick ratio.
So what is the value of AbbVie Inc.? Well its PEG is 1.16, and the P/S is 4.28, along with a P/B of 22.17. Meanwhile it has a p/cash of 11.83.